Download Citation
Article Source:
Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer
Shoemaker RH,
Panettieri RA Jr,
Libutti SK,
Hochster HS,
Watts NR,
et al.
(2022)
Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer.
PLOS ONE 17(7): e0271066.
https://doi.org/10.1371/journal.pone.0271066